QureTech Bio
PrivateLast Round
VC Round
Sep 23, 2024
Total Funding Raised
$830,000
Momentum
Top 50%
of companies Caplight tracks
Company Overview
QureTech Bio operates in Healthcare & Life Sciences and is based in Umeå. Its latest recorded funding round was a VC Round in October 2020.
QureTech Bio is a biotechnology company developing new solutions to combat disease-causing bacteria and tackle antimicrobial resistance.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
QureTech Bio Comparables
Compare QureTech Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Helperby Therapeutics | 81% | |
| Antabio | 80% | |
| Nosopharm | 80% |
For institutional investors. Book with your work email.
QureTech Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Sep 23, 2024 | ||||
| VC Round | Oct 26, 2020 | ||||
| Grant | Apr 21, 2020 | ||||
| Grant | Dec 18, 2019 | ||||
| Seed | Oct 2, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
QureTech Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Vinnova | Grant |
| Swelife | Grant |
| Erling-Persson Foundation | Grant |
| Nascent Invest | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors grew 156% MoM, reaching 2.4K.
- Nov 16, 2024
Monthly visitors grew 91% MoM, reaching 2.1K.
For institutional investors. Book with your work email.
QureTech Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about QureTech Bio's valuation, stock price, and market status.
Is QureTech Bio a public or private company?
QureTech Bio is a private company.
What is the current stock price of QureTech Bio?
QureTech Bio is a private company, so its shares have no public market price. Caplight tracks QureTech Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is QureTech Bio worth (valuation)?
Valuation information for QureTech Bio is not publicly available.
Can I buy QureTech Bio stock?
QureTech Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was QureTech Bio's last funding round?
QureTech Bio's most recent funding round was VC Round on September 23, 2024.
Who are the main investors in QureTech Bio?
Key investors in QureTech Bio include Vinnova, Swelife, Erling-Persson Foundation, Nascent Invest.
Will QureTech Bio IPO soon?
No public IPO plans have been announced for QureTech Bio.
How can I track QureTech Bio secondary market activity?
Caplight tracks bids, offers, and trades in QureTech Bio's shares on secondary markets.